title: Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation.
abstract: Human butyrylcholinesterase (hBChE) hydrolyzes or scavenges a wide range of toxic esters, including heroin, cocaine, carbamate pesticides, organophosphorus pesticides, and nerve agents. Organophosphates (OPs) exert their acute toxicity through inhibition of acetylcholinesterase (AChE) by phosphorylation of the catalytic serine. Phosphylated cholinesterase (ChE) can undergo a spontaneous, time-dependent process called "aging", during which the OP-ChE conjugate is dealkylated. This leads to irreversible inhibition of the enzyme. The inhibition of ChEs by tabun and the subsequent aging reaction are of particular interest, because tabun-ChE conjugates display an extraordinary resistance toward most current oxime reactivators. We investigated the structural basis of oxime resistance for phosphoramidated ChE conjugates by determining the crystal structures of the non-aged and aged forms of hBChE inhibited by tabun, and by updating the refinement of non-aged and aged tabun-inhibited mouse AChE (mAChE). Structures for non-aged and aged tabun-hBChE were refined to 2.3 and 2.1 A, respectively. The refined structures of aged ChE conjugates clearly show that the aging reaction proceeds through O-dealkylation of the P(R) enantiomer of tabun. After dealkylation, the negatively charged oxygen forms a strong salt bridge with protonated His438N epsilon2 that prevents reactivation. Mass spectrometric analysis of the aged tabun-inhibited hBChE showed that both the dimethylamine and ethoxy side chains were missing from the phosphorus. Loss of the ethoxy is consistent with the crystallography results. Loss of the dimethylamine is consistent with acid-catalyzed deamidation during the preparation of the aged adduct for mass spectrometry. The reported 3D data will help in the design of new oximes capable of reactivating tabun-ChE conjugates.
authors.affiliation: Département de Toxicologie, Centre de Recherches du Service de Santé des Armées, 38700 La Tronche, France.
authors.forename: Eugénie
authors.initials: E
authors.lastname: Carletti
authors.forename: He
authors.initials: H
authors.lastname: Li
authors.forename: Bin
authors.initials: B
authors.lastname: Li
authors.forename: Fredrik
authors.initials: F
authors.lastname: Ekström
authors.forename: Yvain
authors.initials: Y
authors.lastname: Nicolet
authors.forename: Mélanie
authors.initials: M
authors.lastname: Loiodice
authors.forename: Emilie
authors.initials: E
authors.lastname: Gillon
authors.forename: Marie T
authors.initials: MT
authors.lastname: Froment
authors.forename: Oksana
authors.initials: O
authors.lastname: Lockridge
authors.forename: Lawrence M
authors.initials: LM
authors.lastname: Schopfer
authors.forename: Patrick
authors.initials: P
authors.lastname: Masson
authors.forename: Florian
authors.initials: F
authors.lastname: Nachon
mesh_terms: D000478:Alkylation; D020134:Catalytic Domain; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000494:pharmacology; D002802:Cholinesterases / Q000737:chemistry* / Q000378:metabolism*; D018360:Crystallography, X-Ray; D006801:Humans; D013058:Mass Spectrometry; D008958:Models, Molecular; D015394:Molecular Structure; D010755:Organophosphates / Q000737:chemistry*; D010766:Phosphorylation
chemical_list: D002800:Cholinesterase Inhibitors; D010755:Organophosphates; D002802:Cholinesterases; C009374:tabun